Seven Eight Capital, LP Neurocrine Biosciences Inc Transaction History

Seven Eight Capital, LP

$1.05 Billion
Q3 2024

A detailed history of Seven Eight Capital, LP transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Seven Eight Capital, LP holds 64,883 shares of NBIX stock, worth $8.79 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares

64,883

Previous 7,862 725.27%

Holding current value

$8.79 Million

Previous $1.08 Million 590.3%

% of portfolio

0.71%

Previous 0.12%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$114.58 - $153.15 $6.53 Million - $8.73 Million	57,021 Added 725.27%	64,883 $7.47 Million
Q2 2024 Aug 12, 2024	BUY	$130.86 - $143.19 $810,023 - $886,346	6,190 Added 370.22%	7,862 $1.08 Million
Q1 2024 May 13, 2024	SELL	$130.4 - $143.74 $722,807 - $796,750	-5,543 Reduced 76.83%	1,672 $230,000
Q4 2023 Feb 13, 2024	BUY	$106.07 - $132.76 $765,295 - $957,863	7,215 New	7,215 $950,000
Q2 2023 Aug 14, 2023	BUY	$89.53 - $104.87 $575,677 - $674,314	6,430 New	6,430 $606,000
Q4 2022 Feb 13, 2023	BUY	$106.72 - $127.06 $192,522 - $229,216	1,804 New	1,804 $215,000
Q4 2021 Feb 14, 2022	SELL	$79.65 - $106.22 $288,014 - $384,091	-3,616 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$86.18 - $99.03 $311,626 - $358,092	3,616 New	3,616 $347,000
Q4 2020 Feb 09, 2021	SELL	$86.91 - $108.33 $1.76 Million - $2.2 Million	-20,300 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$96.16 - $135.15 $1.95 Million - $2.74 Million	20,300 New	20,300 $1.95 Million
Q1 2020 May 14, 2020	SELL	$75.11 - $113.76 $4.96 Million - $7.51 Million	-66,038 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$86.8 - $118.57 $778,509 - $1.06 Million	8,969 Added 15.72%	66,038 $7.1 Million
Q3 2019 Nov 14, 2019	BUY	$83.82 - $101.5 $4.78 Million - $5.79 Million	57,069 New	57,069 $5.14 Million
Q4 2018 Feb 14, 2019	SELL	$68.32 - $124.36 $1.98 Million - $3.61 Million	-29,000 Closed	0 $0
Q3 2018 Oct 18, 2018	BUY	$98.88 - $125.85 $2.87 Million - $3.65 Million	29,000 New	29,000 $3.57 Million
Q1 2018 May 14, 2018	SELL	$75.88 - $92.43 $2.39 Million - $2.91 Million	-31,500 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$58.53 - $77.59 $1.84 Million - $2.44 Million	31,500	31,500 $2.44 Million

Others Institutions Holding NBIX

# of Institutions

626

Shares Held

94M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.

Account

Seven Eight Capital, LP Neurocrine Biosciences Inc Transaction History